Second-Generation HSP90 Inhibitor Onalespib Blocks mRNA Splicing of Androgen Receptor Variant 7 in Prostate Cancer Cells.
Ferraldeschi, Roberta
Second-Generation HSP90 Inhibitor Onalespib Blocks mRNA Splicing of Androgen Receptor Variant 7 in Prostate Cancer Cells. [electronic resource] - Cancer research 05 2016 - 2731-42 p. digital
Publication Type: Journal Article
1538-7445
10.1158/0008-5472.CAN-15-2186 doi
Animals
Benzamides--pharmacology
Blotting, Western
Cell Line, Tumor
Drug Resistance, Neoplasm--drug effects
HSP90 Heat-Shock Proteins--antagonists & inhibitors
Humans
Immunohistochemistry
Immunoprecipitation
Isoindoles--pharmacology
Male
Mice
Polymerase Chain Reaction
Prostatic Neoplasms--genetics
RNA Splicing--drug effects
RNA, Messenger
Receptors, Androgen--genetics
Xenograft Model Antitumor Assays
Second-Generation HSP90 Inhibitor Onalespib Blocks mRNA Splicing of Androgen Receptor Variant 7 in Prostate Cancer Cells. [electronic resource] - Cancer research 05 2016 - 2731-42 p. digital
Publication Type: Journal Article
1538-7445
10.1158/0008-5472.CAN-15-2186 doi
Animals
Benzamides--pharmacology
Blotting, Western
Cell Line, Tumor
Drug Resistance, Neoplasm--drug effects
HSP90 Heat-Shock Proteins--antagonists & inhibitors
Humans
Immunohistochemistry
Immunoprecipitation
Isoindoles--pharmacology
Male
Mice
Polymerase Chain Reaction
Prostatic Neoplasms--genetics
RNA Splicing--drug effects
RNA, Messenger
Receptors, Androgen--genetics
Xenograft Model Antitumor Assays